Guedez L - Search Results

1

Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes.

Lim MS, Guedez L, Stetler-Stevenson WG, Stetler-Stevenson M. Lim MS, et al. Among authors: guedez l. Ann N Y Acad Sci. 1999 Jun 30;878:522-3. doi: 10.1111/j.1749-6632.1999.tb07715.x. Ann N Y Acad Sci. 1999. PMID: 10415761 No abstract available.

2

Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis.

Guedez L, Mansoor A, Birkedal-Hansen B, Lim MS, Fukushima P, Venzon D, Stetler-Stevenson WG, Stetler-Stevenson M. Guedez L, et al. Blood. 2001 Mar 15;97(6):1796-802. doi: 10.1182/blood.v97.6.1796. Blood. 2001. PMID: 11238122 Free article.

3

Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.

Guedez L, McMarlin AJ, Kingma DW, Bennett TA, Stetler-Stevenson M, Stetler-Stevenson WG. Guedez L, et al. Am J Pathol. 2001 Apr;158(4):1207-15. doi: 10.1016/S0002-9440(10)64070-9. Am J Pathol. 2001. PMID: 11290537 Free PMC article.

4

Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells.

Guedez L, Courtemanch L, Stetler-Stevenson M. Guedez L, et al. Blood. 1998 Aug 15;92(4):1342-9. Blood. 1998. PMID: 9694723 Free article.

5

Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.

Guedez L, Martinez A, Zhao S, Vivero A, Pittaluga S, Stetler-Stevenson M, Raffeld M, Stetler-Stevenson WG. Guedez L, et al. Blood. 2005 Feb 15;105(4):1660-8. doi: 10.1182/blood-2004-04-1385. Epub 2004 Oct 12. Blood. 2005. PMID: 15479729 Free article.

6

In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M. Guedez L, et al. J Clin Invest. 1998 Dec 1;102(11):2002-10. doi: 10.1172/JCI2881. J Clin Invest. 1998. PMID: 9835626 Free PMC article.

7

The role of metalloproteinases and their inhibitors in hematological disorders.

Guedez L, Lim MS, Stetler-Stevenson WG. Guedez L, et al. Crit Rev Oncog. 1996;7(3-4):205-25. doi: 10.1615/critrevoncog.v7.i3-4.40. Crit Rev Oncog. 1996. PMID: 9258603 Review.

8

The prognostic value of TIMP-1 in multiple myeloma.

Guedez L, Stetler-Stevenson WG. Guedez L, et al. Leuk Res. 2010 May;34(5):576-7. doi: 10.1016/j.leukres.2009.10.005. Epub 2009 Oct 29. Leuk Res. 2010. PMID: 19878997 Free PMC article. No abstract available.

9

TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.

Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG. Seo DW, et al. Among authors: guedez l. Cell. 2003 Jul 25;114(2):171-80. doi: 10.1016/s0092-8674(03)00551-8. Cell. 2003. PMID: 12887919 Free article.

10

An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo.

Seo DW, Saxinger WC, Guedez L, Cantelmo AR, Albini A, Stetler-Stevenson WG. Seo DW, et al. Among authors: guedez l. Peptides. 2011 Sep;32(9):1840-8. doi: 10.1016/j.peptides.2011.08.010. Epub 2011 Aug 16. Peptides. 2011. PMID: 21871510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters